← Medpace Holdings, Inc. MEDP
Market Price
$578.86
Market Cap
$16.62B
P/E Ratio
37.88
Revenue (FY 2025)
↑20.0% YoY
$2.53B
3-Yr CAGR: 20.1%
Net Income
↑11.6% YoY
$451.12M
Net Margin: 17.8%
Free Cash Flow
↑19.2% YoY
$681.87M
FCF Yield: 4.10%
EPS (Diluted)
↑21.0% YoY
$15.28
Basic: $15.64
Return on Equity
Efficiency
98.3%
ROA: 498.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MEDP)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $421.6M | — | $114.0M | $13.4M | — | $0.37 | — | $91.7M | $78.2M | — |
| FY 2017 | $436.2M | +3.5% | $128.2M | $39.1M | +191.4% | $0.98 | +164.9% | $97.4M | $85.7M | +9.5% |
| FY 2018 | $704.6M | +61.5% | $176.7M | $73.2M | +87.1% | $1.97 | +101.0% | $156.6M | $140.6M | +64.1% |
| FY 2019 | $861.0M | +22.2% | $222.5M | $100.4M | +37.2% | $2.67 | +35.5% | $201.9M | $184.0M | +30.9% |
| FY 2020 | $925.9M | +7.5% | $259.2M | $145.4M | +44.7% | $3.84 | +43.8% | $258.7M | $227.3M | +23.6% |
| FY 2021 | $1,142.4M | +23.4% | $307.0M | $181.8M | +25.1% | $4.81 | +25.3% | $263.3M | $235.1M | +3.4% |
| FY 2022 | $1,460.0M | +27.8% | $410.1M | $245.4M | +34.9% | $7.28 | +51.4% | $388.1M | $351.2M | +49.4% |
| FY 2023 | $1,885.8M | +29.2% | $498.2M | $282.8M | +15.3% | $8.88 | +22.0% | $433.4M | $396.7M | +13.0% |
| FY 2024 | $2,109.1M | +11.8% | $627.1M | $404.4M | +43.0% | $12.63 | +42.2% | $608.8M | $572.3M | +44.2% |
| FY 2025 | $2,530.2M | +20.0% | $732.5M | $451.1M | +11.6% | $15.28 | +21.0% | $713.2M | $681.9M | +19.2% |
Valuation
Market Price
$578.86
Market Cap
$16.62B
Enterprise Value
N/A
P/E Ratio
37.88
P/B Ratio
36.01
FCF Yield
4.10%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
28.95%
Operating Margin
21.14%
Net Margin
17.83%
Return on Equity (ROE)
98.27%
Return on Assets (ROA)
498.49%
Asset Turnover
27.96x
Revenue 3-Yr CAGR
20.12%
Financial Health & Liquidity
Current Ratio
0.22
Cash Ratio
1.22
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$497.05M
Total Debt
N/A
Book Value / Share
$16.07
Cash Flow Efficiency
Operating Cash Flow
$713.22M
Capital Expenditures (CapEx)
$31.36M
Free Cash Flow
$681.87M
OCF / Revenue
28.19%
FCF / Revenue
26.95%
FCF 3-Yr CAGR
24.76%
Per Share Metrics
EPS (Diluted)
$15.28
EPS (Basic)
$15.64
Dividends / Share
N/A
Book Value / Share
$16.07
EPS YoY Growth
20.98%
Balance Sheet (FY 2025)
Total Assets
$90.50M
Total Liabilities
$408.38M
Stockholders' Equity
$459.07M
Current Assets
$90.50M
Current Liabilities
$408.38M